Gedeon Richter Plc.

Jul 08, 2020

Cariprazine Significantly Improved Negative Symptoms of Schizophrenia Based on Real Life Data from a New Observational Study by Gedeon Richter Plc

Sep 11, 2019

Similar Response Rate but Higher Degrees of Clinical Improvement Were More Likely to Achieve With Cariprazine Compared to Risperidone - A Study by Gedeon Richter Plc

Jun 24, 2019

Experts from Gedeon Richter Discuss if 'Social Egg Freezing' Alleviates or Increases the Pressure Among Women to Have a Baby Early

May 28, 2019

Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression

Apr 16, 2019

Cariprazine Shows Better Cognitive Improving Features and Uniquely Favorable Weight Gain Effect Compared to Other Antipsychotics

Jul 02, 2018

ESHRE 2018: GEDEON RICHTER Announces the Winners of the FORWARD Initiative - a Fertility Research Grant Dedicated to Innovative Reproductive Research

Apr 03, 2018

Allergan and Richter Announce Positive Topline Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression

Dec 18, 2017

Allergan and Richter Announce Positive Topline Results from Phase 3 Study of Cariprazine for the Treatment of Bipolar I Depression